您的位置: 首页 > 农业专利 > 详情页

PROCEDES DE MODULATION DE L'EXPRESSION DE TAU POUR REDUIRE L'AVC ET MODIFIER UN SYMPTOME NEURODEGENERATIF
专利权人:
WASHINGTON UNIVERSITY;ISIS PHARMACEUTICALS, INC.
发明人:
MILLER, TIMOTHY M.,DEVOS, SARAH,BENNETT, C. FRANK,RIGO, FRANK
申请号:
CA2866392
公开号:
CA2866392A1
申请日:
2013.03.14
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
Disclosed herein are methods for reducing expression of Tau mRNA and protein in an animal with Tau antisense compounds. Also disclosed are methods for modulating splicing of Tau mRNA in an animal with Tau antisense compounds. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. Examples of neurodegenerative diseases that can be treated, prevented, and ameliorated with the administration Tau antisense oligonucleotides include Alzheimer's Disease, Fronto-temporal Dementia (FTD), FTDP-17, Progressive Supranuclear Palsy, Chronic Traumatic Encephalopathy, Epilepsy, and Dravet's Syndrome.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充